Show simple item record

dc.contributorSpandidos Publ.es_CL
dc.contributor.authorLobato, Ismelda. [Chile. Universidad de Tarapaca,Arica]es_CL
dc.contributor.authorVillanueva, Hilda [Chile. Universidad de Tarapacá]es_CL
dc.contributor.authorBorquez, Celia [Chile. Universidad de Tarapacá]es_CL
dc.contributor.authorNavarrete, Daniela [Chile. Universidad de Valparaíso]es_CL
dc.contributor.authorAbarca, Juan [Chile. Universidad Mayor]es_CL
dc.date.accessioned2018-09-07T14:11:44Z
dc.date.available2018-09-07T14:11:44Z
dc.date.issued2011es_CL
dc.identifier.citationMontalvo, M. T., Lobato, I., Villanueva, H., Borquez, C., Navarrette, D., Abarca, J., & Calaf, G. M. (2011). Prevalence of human papillomavirus in university young women. Oncology letters, 2(4), 701-706.es_CL
dc.identifier.issnISSN 1792-1074es_CL
dc.identifier.issnESSN 1792-1082es_CL
dc.identifier.urihttps://www.spandidos-publications.com/ol/2/4/701?text=fulltextes_CL
dc.identifier.urihttps://doi.org/10.3892/ol.2011.290es_CL
dc.identifier.urihttps://www.spandidos-publications.com/ol/2/4/701/downloades_CL
dc.identifier.urihttp://repositorio.umayor.cl/xmlui/handle/sibum/2761
dc.description.abstractCervical cancer is the second most prevalent female cancer worldwide. The majority of cases appear between the age of 30 and 50. Human papillomavirus (HPV) plays a central role in cervical cancer with 99.7% of HPV DNA identified in invasive cervical carcinomas. The prevalence of the HPV infection varies substantially among countries and according to age and lifestyle. HPV is a common sexually transmitted infection among males and females with a 70% higher incidence in sexually active females. This study aimed to determine the prevalence of human papillomavirus in young university women by analyzing the correlation between Papanicolaou (PAP)-stained cervical tests and HPV detection by genotyping, as well as other risk factors. A total of 200 women aged between 18 and 25 years were enrolled in this study, which took place between September 2008 and May 2009 at the Universidad de Tarapaca, Arica, Chile. Results of the PAP smears showed that 97.5% of cells had normal characteristics, although an inflammatory pattern was noted. The prevalence of generic HPV infection was 3.5% when testing for HPV DNA using the polymerase chain reaction (PCR) method. An analysis of the genotype of infected female Individuals indicated that high-risk FIPV types, such as FIPV 16 and 31 were present in 42.84 and 14.29% of females, respectively, and low-risk types such as HPV 6, in 14.29%. Only one sample with differentiated non-HPV (14.29%) was found. A 95% correlation between PAP-stained cervical tests and the method of testing for HPV was observed. Using the PCR method, it was found that of the 195 negative PAP smears, 5 were positive for HPV and two of the samples that were positive for ASC-US were also positive. A significantly increased (P < 0.05) HPV infection risk was observed in the 18-21 age group with a higher prevalence (71.40%) when compared to the 22-25 age group (28.6%). A significant (P < 0.042) difference was found between smoking and HPV infection. In conclusion, a significant (P < 0.05) correlation was found between PAP and PCR methods for HPV testing in young university women. A significant correlation between smoking and HPV was detected, whereas no difference was noted with other parameters.es_CL
dc.description.sponsorshipEste trabajo fue financiado por: Grant UTA Mayor 7710-08, Universidad de Tarapacá, Chile; FONDECYT Concurso Nacional Regular 2008 N° 1080482.es_CL
dc.format.extentARTÍCULO ORIGINALes_CL
dc.language.isoenes_CL
dc.publisherCIENCIASes_CL
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chilees_CL
dc.subjectONCOLOGÍAes_CL
dc.titlePrevalence of human papillomavirus university young womenes_CL
dc.typeArtículo o Paperes_CL
umayor.indizadorCOTes_CL
umayor.politicas.sherpa/romeoLicencia color: BLANCO (El archivo no está formalmente admitido)--Pre-print del autor: el autor no puede archivar la versión pre-print (ie la versión previa a la revisión por pares) Post-print del autor: el autor no puede archivar la versión post-print (ie la versión final posterior a la revisión por pares) Versión de editor/PDF: el autor puede archivar la versión PDF de la editorial siempre que se cumplan las restricciones: 6 meses de embargo. Condiciones generales: La versión de editor/PDF debe utilizarse, On Institutional Repository or Funder's repository, Debe ir enlazado a la versión de editor, La fuente publicada debe reconocerse con la cita completa, Publisher will automatically deposit authors post-print in PubMed Central or Europe PMC after 6 months or 12 months as required by funding agency// Disponible en: http://www.sherpa.ac.uk/romeo/issn/1792-1074/es/es_CL
umayor.indexadoWOSes_CL
dc.identifier.doi10.3892/ol.2011.290es_CL]
umayor.indicadores.wos-(cuartil)Q4es_CL
umayor.indicadores.scopus-(scimago-sjr)sin informaciónes_CL


Show simple item record